Elsässer-Beile U, Wetterauer U, Schultze-Seemann W, Gallati H, Mönting J S, von Kleist S
Urological Department, University of Freiburg, Germany.
Cancer Immunol Immunother. 1996 Feb;42(2):93-8. doi: 10.1007/s002620050257.
The immunological properties of tumour-infiltrating (TIL) and peripheral blood lymphocytes (PBL) from 29 patients with renal cell carcinomas were characterized with respect to their phenotypic expression and cytokine production. TIL were isolated from mechanically disaggregated tumor material and PBL from peripheral blood by gradient centrifugation. To eliminate all non-lymphoid cells, CD3-positive cells were specifically separated from these cell fractions with anti-CD3 magnetic beads. These pure CD3-positive PBL (CD3+PBL) and TIL (CD3+TIL) were cultured with pokeweed mitogen and the levels of the cytokines interleukin-1alpha (IL-1 alpha), IL-1 beta, IL-2, interferon gamma (IFNgamma), and tumor necrosis factor alpha (TNFalpha) measured in the 4-day post-inductional cell culture supernatants. In all cell cultures a wide range of cytokine values was found, indicating a large variation in the immunological activity of the lymphocytes of each individual. When the cell cultures of the CD3+TIL and CD3+PBL were compared in each patient similar values for IL-1 alpha, IL-1 beta, IFNgamma and TNFalpha were found. However CD3+TIL produced significantly lower levels of IL-2 than CD3+PBL upon mitogenic stimulation. This may be due to a lower CD4/CD8 ratio in the CD3+TIL as compared to the CD3+PBL. These results suggest that there are no fundamental qualitative and quantitative differences in the lymphokine-producing capacity of CD3+TIL and CD3+PBL derived from patients with renal cell carcinomas.
对29例肾细胞癌患者的肿瘤浸润淋巴细胞(TIL)和外周血淋巴细胞(PBL)的免疫特性进行了表型表达和细胞因子产生方面的特征分析。TIL从机械分离的肿瘤组织中分离,PBL通过梯度离心从外周血中分离。为了消除所有非淋巴细胞,用抗CD3磁珠从这些细胞组分中特异性分离出CD3阳性细胞。将这些纯的CD3阳性PBL(CD3 + PBL)和TIL(CD3 + TIL)与商陆有丝分裂原一起培养,并在诱导后4天的细胞培养上清液中测量细胞因子白细胞介素-1α(IL-1α)、IL-1β、IL-2、干扰素γ(IFNγ)和肿瘤坏死因子α(TNFα)的水平。在所有细胞培养物中发现了广泛的细胞因子值范围,表明每个个体淋巴细胞的免疫活性存在很大差异。当比较每位患者的CD3 + TIL和CD3 + PBL的细胞培养物时,发现IL-1α、IL-1β、IFNγ和TNFα的值相似。然而,在有丝分裂原刺激下,CD3 + TIL产生的IL-2水平明显低于CD3 + PBL。这可能是由于与CD3 + PBL相比,CD3 + TIL中的CD4/CD8比值较低。这些结果表明,来自肾细胞癌患者的CD3 + TIL和CD3 + PBL在产生淋巴因子的能力上没有根本的质和量的差异。